Skip to main content
Erschienen in: Calcified Tissue International 3/2013

01.09.2013 | Original Research

The Effect of Endogenous Parathyroid Hormone in Iliac Bone Structure and Turnover in Healthy Postmenopausal Women

verfasst von: D. Sudhaker Rao, Nayana Parikh, Saroj Palnitkar, Shijing Qiu

Erschienen in: Calcified Tissue International | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Little is known about the effect of endogenous parathyroid hormone (PTH) on the skeleton in postmenopausal women without hyperparathyroidism. In this study, the effects of PTH on bone were investigated in iliac crest biopsies obtained from 37 healthy white postmenopausal women aged 50–73 years. The results showed that neither cancellous nor cortical bone structure changed with serum PTH levels. In cancellous bone, bone formation (wall thickness, osteoid surface, osteoblast surface, mineralizing surface, and mineral apposition rate) and turnover (bone formation rate at the surface, volume levels, and activation frequency) variables increased with increasing serum PTH levels (all p < 0.05) in univariate analysis. Multiple linear regressions, adjusted for serum 25-OHD, calcium, alkaline phosphatase, age, and BMI, showed that serum PTH level was independently associated with wall thickness, osteoid surface, osteoblast surface, mineralizing surface, and bone formation rate (all p < 0.05). In cortical bone, no histomorphometric variable was correlated with PTH levels. On the endosteal surface, some of the bone formation (osteoid surface, osteoblast surface, mineralizing surface) and turnover (bone formation rate at the bone surface levels and activation frequency) variables were positively correlated with PTH levels (all p < 0.05). None of these variables could be independently predicted by PTH status. We conclude that in healthy postmenopausal women endogenous PTH has a positive effect on bone formation on the cancellous surface. The effects of PTH on the endosteal surface are probably confounded by other factors.
Literatur
1.
Zurück zum Zitat Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP (2011) Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Invest 34:801–810PubMed Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP (2011) Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Invest 34:801–810PubMed
2.
Zurück zum Zitat Rubin MR, Cosman F, Lindsay R, Bilezikian JP (2002) The anabolic effects of parathyroid hormone. Osteoporos Int 13:267–277PubMedCrossRef Rubin MR, Cosman F, Lindsay R, Bilezikian JP (2002) The anabolic effects of parathyroid hormone. Osteoporos Int 13:267–277PubMedCrossRef
3.
Zurück zum Zitat Khan A, Bilezikian J (2000) Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163:184–187PubMed Khan A, Bilezikian J (2000) Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163:184–187PubMed
4.
Zurück zum Zitat Eriksen EF (2002) Primary hyperparathyroidism: lessons from bone histomorphometry. J Bone Miner Res 17(Suppl 2):N95–N97PubMed Eriksen EF (2002) Primary hyperparathyroidism: lessons from bone histomorphometry. J Bone Miner Res 17(Suppl 2):N95–N97PubMed
5.
Zurück zum Zitat Miller PD, Bilezikian JP (2002) Bone densitometry in asymptomatic primary hyperparathyroidism. J Bone Miner Res 17(Suppl 2):N98–N102PubMed Miller PD, Bilezikian JP (2002) Bone densitometry in asymptomatic primary hyperparathyroidism. J Bone Miner Res 17(Suppl 2):N98–N102PubMed
6.
Zurück zum Zitat Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP (1999) On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84:1562–1566PubMedCrossRef Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP (1999) On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84:1562–1566PubMedCrossRef
7.
Zurück zum Zitat Parisien M, Mellish RW, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW (1992) Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 7:913–919PubMedCrossRef Parisien M, Mellish RW, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW (1992) Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 7:913–919PubMedCrossRef
8.
Zurück zum Zitat Silverberg SJ, Bilezikian JP (1997) Primary hyperparathyroidism: still evolving? J Bone Miner Res 12:856–862PubMedCrossRef Silverberg SJ, Bilezikian JP (1997) Primary hyperparathyroidism: still evolving? J Bone Miner Res 12:856–862PubMedCrossRef
9.
Zurück zum Zitat Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688–703PubMedCrossRef Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688–703PubMedCrossRef
10.
Zurück zum Zitat Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J (2009) Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1–84. Bone 44:113–119PubMedCrossRef Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J (2009) Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1–84. Bone 44:113–119PubMedCrossRef
11.
Zurück zum Zitat Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422PubMedCrossRef Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422PubMedCrossRef
12.
Zurück zum Zitat Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ (2004) The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35:312–319PubMedCrossRef Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ (2004) The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35:312–319PubMedCrossRef
13.
Zurück zum Zitat Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610PubMedCrossRef Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610PubMedCrossRef
14.
Zurück zum Zitat Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM (1996) Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res 11:1967–1975PubMedCrossRef Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM (1996) Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res 11:1967–1975PubMedCrossRef
15.
Zurück zum Zitat Rao DS (1983) Practical approach to bone biopsy. In: Recker R (ed) Bone histomorphometry: techniques and interpretations. CRC Press, Boca Raton, pp 3–11 Rao DS (1983) Practical approach to bone biopsy. In: Recker R (ed) Bone histomorphometry: techniques and interpretations. CRC Press, Boca Raton, pp 3–11
16.
Zurück zum Zitat Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17PubMedCrossRef Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17PubMedCrossRef
17.
Zurück zum Zitat Parfitt AM (1976) The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation. Metabolism 25:909–955PubMedCrossRef Parfitt AM (1976) The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation. Metabolism 25:909–955PubMedCrossRef
18.
Zurück zum Zitat Parfitt AM (1976) The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover. Metabolism 25:809–844PubMedCrossRef Parfitt AM (1976) The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover. Metabolism 25:809–844PubMedCrossRef
19.
Zurück zum Zitat Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH (2000) Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH (1–34) therapy in women with severe osteoporosis. Bone 27:311–318PubMedCrossRef Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH (2000) Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH (1–34) therapy in women with severe osteoporosis. Bone 27:311–318PubMedCrossRef
20.
Zurück zum Zitat Syed Z, Khan A (2000) Skeletal effects of primary hyperparathyroidism. Endocr Pract 6:385–388PubMedCrossRef Syed Z, Khan A (2000) Skeletal effects of primary hyperparathyroidism. Endocr Pract 6:385–388PubMedCrossRef
21.
22.
Zurück zum Zitat Dempster DW, Muller R, Zhou H, Kohler T, Shane E, Parisien M, Silverberg SJ, Bilezikian JP (2007) Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone 41:19–24PubMedCrossRef Dempster DW, Muller R, Zhou H, Kohler T, Shane E, Parisien M, Silverberg SJ, Bilezikian JP (2007) Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone 41:19–24PubMedCrossRef
23.
Zurück zum Zitat Maggio D, Cherubini A, Lauretani F, Russo RC, Bartali B, Pierandrei M, Ruggiero C, Macchiarulo MC, Giorgino R, Minisola S, Ferrucci L (2005) 25(OH)D serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. J Gerontol A 60:1414–1419CrossRef Maggio D, Cherubini A, Lauretani F, Russo RC, Bartali B, Pierandrei M, Ruggiero C, Macchiarulo MC, Giorgino R, Minisola S, Ferrucci L (2005) 25(OH)D serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. J Gerontol A 60:1414–1419CrossRef
24.
Zurück zum Zitat Guardia G, Parikh N, Eskridge T, Phillips E, Divine G, Rao DS (2008) Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications. Osteoporos Int 19:13–19PubMedCrossRef Guardia G, Parikh N, Eskridge T, Phillips E, Divine G, Rao DS (2008) Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications. Osteoporos Int 19:13–19PubMedCrossRef
25.
Zurück zum Zitat Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, Diaz-Lopez JB, Fernandez-Coto MT, Cannata-Andia JB (2003) Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl 85:S44–S48PubMedCrossRef Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, Diaz-Lopez JB, Fernandez-Coto MT, Cannata-Andia JB (2003) Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl 85:S44–S48PubMedCrossRef
26.
Zurück zum Zitat Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294:2336–2341PubMedCrossRef Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294:2336–2341PubMedCrossRef
27.
Zurück zum Zitat Gallagher JC, Yalamanchili V, Smith LM (2012) The effect of vitamin D on calcium absorption in older women. J Clin Endocrinol Metab 97:3550–3556PubMedCrossRef Gallagher JC, Yalamanchili V, Smith LM (2012) The effect of vitamin D on calcium absorption in older women. J Clin Endocrinol Metab 97:3550–3556PubMedCrossRef
28.
Zurück zum Zitat Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325PubMedCrossRef Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325PubMedCrossRef
29.
Zurück zum Zitat Seeman E (2003) Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 14(Suppl 3):2–8 Seeman E (2003) Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 14(Suppl 3):2–8
30.
Zurück zum Zitat Kousteni S, Bilezikian JP (2008) The cell biology of parathyroid hormone in osteoblasts. Curr Osteoporos Rep 6:72–76PubMedCrossRef Kousteni S, Bilezikian JP (2008) The cell biology of parathyroid hormone in osteoblasts. Curr Osteoporos Rep 6:72–76PubMedCrossRef
31.
Zurück zum Zitat Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW (1990) The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930–938PubMedCrossRef Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW (1990) The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930–938PubMedCrossRef
32.
Zurück zum Zitat Rao DS, Wallace EA, Antonelli RF, Talpos GB, Ansari MR, Jacobsen G, Divine GW, Parfitt AM (2003) Forearm bone density in primary hyperparathyroidism: long-term follow-up with and without parathyroidectomy. Clin Endocrinol (Oxf) 58:348–354CrossRef Rao DS, Wallace EA, Antonelli RF, Talpos GB, Ansari MR, Jacobsen G, Divine GW, Parfitt AM (2003) Forearm bone density in primary hyperparathyroidism: long-term follow-up with and without parathyroidectomy. Clin Endocrinol (Oxf) 58:348–354CrossRef
33.
Zurück zum Zitat Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Zhou H, Dempster DW, Collins MT (2012) Daily parathyroid hormone 1–34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res 27:1811–1820PubMedCrossRef Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Zhou H, Dempster DW, Collins MT (2012) Daily parathyroid hormone 1–34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res 27:1811–1820PubMedCrossRef
34.
Zurück zum Zitat Bilezikian JP, Rubin MR (2006) Monitoring anabolic treatment. In: Seibel MJ, Robins SP, Bilezikian JP (eds) Dynamics of bone and cartilage metabolism. Academic Press, San Diego, pp 629–647CrossRef Bilezikian JP, Rubin MR (2006) Monitoring anabolic treatment. In: Seibel MJ, Robins SP, Bilezikian JP (eds) Dynamics of bone and cartilage metabolism. Academic Press, San Diego, pp 629–647CrossRef
35.
Zurück zum Zitat Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207–1215PubMedCrossRef Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207–1215PubMedCrossRef
36.
Zurück zum Zitat Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216–1226PubMedCrossRef Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216–1226PubMedCrossRef
37.
Zurück zum Zitat Schaffler MB (2003) Role of bone turnover in microdamage. Osteoporos Int 14(Suppl 5):73–80CrossRef Schaffler MB (2003) Role of bone turnover in microdamage. Osteoporos Int 14(Suppl 5):73–80CrossRef
38.
Zurück zum Zitat Horwitz M, Stewart A, Greenspan SL (2000) Sequential parathyroid hormone/alendronate therapy for osteoporosis—robbing Peter to pay Paul? J Clin Endocrinol Metab 85:2127–2128PubMedCrossRef Horwitz M, Stewart A, Greenspan SL (2000) Sequential parathyroid hormone/alendronate therapy for osteoporosis—robbing Peter to pay Paul? J Clin Endocrinol Metab 85:2127–2128PubMedCrossRef
39.
Zurück zum Zitat Hansen S, Hauge EM, Jensen JE, Brixen K (2012) Differing effects of PTH 1–34, PTH 1–84 and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis. An 18 month open-labeled observational study using HR-pQCT. J Bone Miner Res 28:736–745CrossRef Hansen S, Hauge EM, Jensen JE, Brixen K (2012) Differing effects of PTH 1–34, PTH 1–84 and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis. An 18 month open-labeled observational study using HR-pQCT. J Bone Miner Res 28:736–745CrossRef
40.
Zurück zum Zitat Jilka RL, O’Brien CA, Ali AA, Roberson PK, Weinstein RS, Manolagas SC (2009) Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 44:275–286PubMedCrossRef Jilka RL, O’Brien CA, Ali AA, Roberson PK, Weinstein RS, Manolagas SC (2009) Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 44:275–286PubMedCrossRef
41.
Zurück zum Zitat Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1–34) (teriparatide) improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932–1941PubMedCrossRef Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1–34) (teriparatide) improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932–1941PubMedCrossRef
42.
Zurück zum Zitat Zhang L, Takahashi HE, Inoue J, Tanizawa T, Endo N, Yamamoto N, Hori M (1997) Effects of intermittent administration of low dose human PTH (1–34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 21:501–506PubMedCrossRef Zhang L, Takahashi HE, Inoue J, Tanizawa T, Endo N, Yamamoto N, Hori M (1997) Effects of intermittent administration of low dose human PTH (1–34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 21:501–506PubMedCrossRef
43.
Zurück zum Zitat Ascenzi MG, Liao VP, Lee BM, Billi F, Zhou H, Lindsay R, Cosman F, Nieves J, Bilezikian JP, Dempster DW (2011) Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis. J Bone Miner Res 27:702–712CrossRef Ascenzi MG, Liao VP, Lee BM, Billi F, Zhou H, Lindsay R, Cosman F, Nieves J, Bilezikian JP, Dempster DW (2011) Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis. J Bone Miner Res 27:702–712CrossRef
44.
Zurück zum Zitat Tai K, Dao M, Suresh S, Palazoglu A, Ortiz C (2007) Nanoscale heterogeneity promotes energy dissipation in bone. Nat Mater 6:454–462PubMedCrossRef Tai K, Dao M, Suresh S, Palazoglu A, Ortiz C (2007) Nanoscale heterogeneity promotes energy dissipation in bone. Nat Mater 6:454–462PubMedCrossRef
45.
Zurück zum Zitat Donnelly E, Meredith DS, Nguyen JT, Gladnick BP, Rebolledo BJ, Shaffer AD, Lorich DG, Lane JM, Boskey AL (2011) Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res 27:672–678CrossRef Donnelly E, Meredith DS, Nguyen JT, Gladnick BP, Rebolledo BJ, Shaffer AD, Lorich DG, Lane JM, Boskey AL (2011) Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res 27:672–678CrossRef
46.
Zurück zum Zitat Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R (2001) Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846–1853PubMedCrossRef Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R (2001) Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846–1853PubMedCrossRef
47.
Zurück zum Zitat Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V (2012) Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J Postgrad Med 58:107–111PubMed Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V (2012) Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J Postgrad Med 58:107–111PubMed
Metadaten
Titel
The Effect of Endogenous Parathyroid Hormone in Iliac Bone Structure and Turnover in Healthy Postmenopausal Women
verfasst von
D. Sudhaker Rao
Nayana Parikh
Saroj Palnitkar
Shijing Qiu
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 3/2013
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-013-9756-0

Weitere Artikel der Ausgabe 3/2013

Calcified Tissue International 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.